Fidelity Investments’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$432M Buy
7,368,420
+2,045,535
+38% +$128M 0.02% 582
2026
Q2
$294M Buy
5,322,885
+2,386,201
+81% +$83.3M 0.01% 768
2026
Q1
$87.7M Buy
2,936,684
+2,920,938
+18,550% +$99.3M ﹤0.01% 1235
2025
Q4
$497K Sell
15,746
-53,230
-77% -$1.29M ﹤0.01% 3086
2025
Q3
$1.21M Buy
68,976
+7,643
+12% +$102K ﹤0.01% 2729
2025
Q2
$700K Buy
61,333
+17,093
+39% +$174K ﹤0.01% 2843
2025
Q1
$326K Buy
44,240
+19,667
+80% +$208K ﹤0.01% 3055
2024
Q4
$453K Buy
+24,573
New +$524K ﹤0.01% 2970

Other funds holding MBX

Fidelity Investments's MBX Position: Q3 2026 in Review

Fidelity Investments increased its MBX Biosciences (MBX) stake by 38% in Q3 2026, buying an estimated $128M and bringing the position to 7,368,420 shares worth $432M. The position accounts for 0.02% of the portfolio, ranked #582.

Fidelity Investments first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 130 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Fidelity Investments held 7,368,420 shares of MBX Biosciences worth $432M as of Q3 2026.
  • Fidelity Investments bought 2,045,535 MBX Biosciences shares in Q3 2026, an estimated $128M.
  • MBX Biosciences made up 0.02% of Fidelity Investments's portfolio in Q3 2026, its #582 holding.
  • Fidelity Investments first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 130 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.